Blood Glucose Monitoring Devices Market Share

  • Report ID: 4606
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Blood Glucose Monitoring Devices Market Regional Analysis:

North American Market Insights

North America region is expected to account for more than 38.8% market share by 2035, driven by rising diabetes cases and increasing adoption of advanced monitoring devices. For instance, it was estimated that around 32.2 million people in the United States, were suffering from diabetes in 2021. Further, the huge investment in research and development activities, along with the increasing adoption of technologically advanced devices, are some further factors that are anticipated to boost the market growth. In addition, the expanding per capita medical expenditure is also anticipated to drive the market growth further during the projected time frame.

APAC Market Insights

Further, the Asia Pacific blood glucose monitoring devices market is also estimated to display lucrative revenue by the end of 2035. The growth of the market can be attributed to the large pool of diabetes patients who have been dealing with insulin-dependent diabetes, along with the escalating ratio of aged people in the region. In addition to this, rising awareness about diabetes preventive care, followed by improving healthcare facilities are some more factors that are anticipated to drive the growth of the market in the region throughout the forecast period.

Blood Glucose Monitoring Devices Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of blood glucose monitoring devices is assessed at USD 21.16 billion.

The global blood glucose monitoring devices market size was valued at around USD 19.71 billion in 2025 and is projected to grow at a CAGR of more than 8.2%, reaching USD 43.35 billion revenue by 2035.

North America blood glucose monitoring devices market is predicted to capture 38.8% share by 2035, driven by rising diabetes cases and increasing adoption of advanced monitoring devices.

Key players in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., NIPRO CORPORATION, Prodigy Diabetes Care, LLC, ACON Laboratories, Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos